“Fluicell is advancing in the right direction” interview with CEO Victoire Viannay

Our plan is to continue to advance in all our three business areas: research solutions, human in vitro models, and regenerative medicine. These three areas represent rapidly growing markets where Fluicell can deliver a key advantage to meet existing and future needs. Our ambition is to transform how we treat diseases, and we believe that we have the right technology and know-how to do so.

Fluicell’s CEO Victoire Viannay spoke to analyst group about what is going on at Fluicell and what our plans for the future are. Watch the interview here: https://www.youtube.com/watch?v=EJcpzLR7wkg